LXR activation inhibits chemokine-induced CD4-positive lymphocyte migration

Basic Research in Cardiology

Volumn 105, Issue 4, 2010, Pages 487-494

  Walcher, Daniel ^a   Vasic, Dusica ^a   Heinz, Philipp ^a   Bach, Helga ^a   Durst, Renate ^a   Hausauer, Angelina ^a   Hombach, Vinzenz ^a   Marx, Nikolaus ^b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

CD4 positive lymphocytes; Liver x receptor; Migration

Indexed keywords

3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; CHEMOKINE; F ACTIN; GUANOSINE TRIPHOSPHATASE; INTERCELLULAR ADHESION MOLECULE 3; LIVER X RECEPTOR; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; MYOSIN LIGHT CHAIN; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; RAC PROTEIN; SMALL INTERFERING RNA; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; ATHEROGENESIS; CD4+ T LYMPHOCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE TRANSLOCATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; INTRACELLULAR SIGNALING; LEUKOCYTE MIGRATION; NORMAL HUMAN; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RNA INTERFERENCE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACTINS; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; CELL MIGRATION ASSAYS, LEUKOCYTE; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL5; CHEMOKINE CXCL12; HUMANS; HYDROCARBONS, FLUORINATED; MYOSIN LIGHT CHAINS; ORPHAN NUCLEAR RECEPTORS; PHOSPHORYLATION; RAC1 GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; SULFONAMIDES;

EID: 77953122862     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-010-0092-5     Document Type: Article

References (25)

1. Al-Aoukaty A, Rolstad B, Maghazachi AA (1999) Recruitment of pleckstrin and phosphoinositide 3-kinase gamma into the cell membranes, and their association with G beta gamma after activation of NK cells with chemokines. J Immunol 162:3249-3255
2. Arber S, Barbayannis FA, Hanser H, Schneider C, Stanyon CA, Bernard O, Caroni P (1998) Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 393:805-809 (Pubitemid 28299494)
3. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, Dewor M, Georgiev I, Schober A, Leng L, Kooistra T, Fingerle-Rowson G, Ghezzi P, Kleemann R, McColl SR, Bucala R, Hickey MJ, Weber C (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13:587-596
4. Braunersreuther V, Zernecke A, Arnaud C, Liehn EA, Steffens S, Shagdarsuren E, Bidzhekov K, Burger F, Pelli G, Luckow B, Mach F, Weber C (2007) Ccr5 but not Ccrl deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler Thromb Vase Biol 27:373-379
5. Dunaeva M, Voo S, van Oosterhoud C, Waltenberger J (2010) Sonic hedgehog is a potent chemoattractant for human monocytes: diabetes mellitus inhibits Sonic hedgehog-induced monocyte Chemotaxis. Basic Res Cardiol 105:61-71
6. Fontaine C, Rigamonti E, Nohara A, Gervois P, Teissier E, Fruchart JC, Staels B, Chinetti-Gbaguidi G (2007) Liver X receptor activation potentiates the lipopolysaccharide response in human macrophages. Circ Res 101:40-49 (Pubitemid 47094622)
7. Goetze S, Eilers F, Bungenstock A, Kintscher U, Stawowy P, Blaschke F, Graf K, Law RE, Fleck E, Gräfe M (2002) PPAR activators inhibit endothelial cell migration by targeting Akt. Biochem Biophys Res Commun 293:1431-1437
8. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685-1695
9. Heller EA, Liu E, Tager AM, Yuan Q, Lin AY, Ahluwalia N, Jones K, Koehn SL, Lok VM, Aikawa E, Moore KJ, Luster AD, Gerszten RE (2006) Chemokine CXCLlO promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation 113:2301-2312 (Pubitemid 43947976)
10. Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P (2003) Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 9:213-219 (Pubitemid 36227724)
11. Joseph SB, McKilligin E, Pei L, Watson MA, Collins AR, Laffitte BA, Chen M, Noh G, Goodman J, Hagger GN, Tran J, Tippin TK, Wang X, Lusis AJ, Hsueh WA, Law RE, Collins JL, Willson TM, Tontonoz P (2002) Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci USA 99:7604-7609
12. Lund EG, Menke JG, Sparrow CP (2003) Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis. Arterioscler Thromb Vase Biol 23:1169-1177 (Pubitemid 36873813)
13. Maggiolini M, Picard D (2010) The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endocrinol 204:105114
14. Ryu JW, Hong KH, Maeng JH, Kim JB, Ko J, Park JY, Lee KU, Hong MK, Park SW, Kim YH, Han KH (2004) Overexpression of uncoupling protein 2 in THP1 monocytes inhibits beta2 integrin-mediated firm adhesion and transendothelial migration. Arterioscler Thromb Vase Biol 24:864-870
15. Sanchez-Madrid F, del Pozo MA (1999) Leukocyte polarization in cell migration and immune interactions. EMBO J 18:501-511 (Pubitemid 29057235)
16. Serrador JM, Nieto M, Sanchez-Madrid F (1999) Cytoskeletal rearrangement during migration and activation of T lymphocytes. Trends Cell Biol 9:228-233
17. Stenson BM, Rydén M, Steffensen KR, Wåhlén K, Pettersson AT, Jocken JW, Arner P, Laurencikiene J (2009) Activation of liver X receptor (LXR) regulates substrate oxidation in white adipocytes. Endocrinology 150:4104-4113
18. Tangirala RK, Bischoff ED, Joseph SB, Wagner BL, Walczak R, Laffitte BA, Daige CL, Thomas D, Heyman RA, Mangelsdorf DJ, Wang X, Lusis AJ, Tontonoz P, Schulman IG (2002) Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc Natl Acad Sci USA 99:11896-11901
19. Tontonoz P, Mangelsdorf DJ (2003) Liver X receptor signaling pathways in cardiovascular disease. MoI Endocrinol 17:985-993 (Pubitemid 36683707)
20. Veillard NR, Steffens S, Pelli G, Lu B, Kwak BR, Gerard C, Charo IF, Mach F (2005) Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo. Circulation 112:870-878 (Pubitemid 41170074)
21. Walcher D, Kümmel A, Kehrle B, Bach H, Betz S, Durst R, Grüb M, Hombach V, Marx N (2006) Liver-X-receptor activation reduces proinflammatory cytokine expression in human CD4 positive lymphocytes. Arterioscler Thromb Vase Biol 26:1022-1028
22. Walcher D, Aleksic M, Jerg V, Hombach V, Zieske A, Homma S, Strong J, Marx N (2004) C-peptide induces Chemotaxis of human CD4-positive lymphocytes-involvement of pertussis toxin-sensitive G-proteins and PI 3-kinase. Diabetes 53:1664-1670
23. Walcher D, Hess K, Heinz P, Vasic D, Petscher K, Kintscher U, Clemenz M, Raps K, Hombach V, Marx N (2008) Telmisartan inhibits CD4-positive lymphocyte migration independent of the angiotensin-1 receptor via PPARgamma. Hypertension 51:259266
24. Zelcer N, Hong C, Boyadjian R, Tontonoz P (2009) LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 325:100-104
25. Zernecke A, Weber C (2005) Inflammatory mediators in atherosclerotic vascular disease. Basic Res Cardiol 100:93-101 (Pubitemid 40361602)